RetinaRounds™

30: RetinaRounds™ Podcast 30: Jay Duker, MD

58 min · 21. Dez. 2025
Episode 30: RetinaRounds™ Podcast 30: Jay Duker, MD Cover

Beschreibung

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

Kommentare

0

Sei die erste Person, die kommentiert

Melde dich jetzt an und werde Teil der RetinaRounds™-Community!

Loslegen

2 Monate für 1 €

Dann 4,99 € / Monat · Jederzeit kündbar.

  • Podcasts nur bei Podimo
  • 20 Stunden Hörbücher / Monat
  • Alle kostenlosen Podcasts

Alle Folgen

31 Folgen

Episode 30: RetinaRounds™ Podcast 30: Jay Duker, MD Cover

30: RetinaRounds™ Podcast 30: Jay Duker, MD

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

21. Dez. 202558 min